Please use this identifier to cite or link to this item: https://open.uns.ac.rs/handle/123456789/9318
Title: Pleiotropic functions of bile acids mediated by the farnesoid X receptor
Authors: Stanimirov, Bojan 
Stankov, Karmen 
Mikov, Momir 
Issue Date: 1-Dec-2012
Journal: Acta Gastro-Enterologica Belgica
Abstract: In addition to their well-established role in the digestion and absorption of dietary lipids, bile acids (BAs) are recognized as signalling molecules in a wide range of metabolic processes. Bile acids regulate their own metabolism and enterohepatic circulation by activating the farnesoid X receptor (FXR). BAs have been shown to affect lipid metabolism, to decrease levels of circulating triglycerides, improve hyperglycemia and insulin signalling, directly act on the arterial wall and protect hepatocytes against cholestatic liver injury. Given that BAs are an integrated part of the complex metabolic network regulated by FXR, acting as a major underlying pathway, specific therapeutic targeting of this nuclear receptor represents an attractive therapeutic approach for a wide range of disorders. During a phase II clinical trial, the administration of a semisynthetic BA derivative 6-ethyl-chenodeoxycholic acid (6- ECDCA) to patients with diabetes, non-alcoholic fatty liver disease (NAFLD) and primary biliary cirrhosis (PBC), led to encouraging results, despite side effects being observed in pre-clinical studies. Chemical manipulations of the side chain and the steroid nucleus of BAs could lead to the discovery of novel semisynthetic BA derivatives that are more specific and selective FXR activators.
URI: https://open.uns.ac.rs/handle/123456789/9318
ISSN: 15644
Appears in Collections:MDF Publikacije/Publications

Show full item record

SCOPUSTM   
Citations

27
checked on May 6, 2023

Page view(s)

24
Last Week
7
Last month
0
checked on May 10, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.